From: Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
Acute myocardial infarction* | Haemorrhagic cerebral infarction |
Basal ganglia infarction | Haemorrhagic stroke* |
Basilar artery thrombosis | Haemorrhagic transformation stroke |
Brain stem infarction* | Ischaemic cerebral infarction |
Brain stem stroke | Ischaemic stroke* |
Brain stem thrombosis | Lacunar infarction* |
Carotid arterial embolus | Lateral medullary syndrome |
Carotid artery thrombosis | Moyamoya disease |
Cerebellar artery thrombosis | Myocardial infarction* |
Cerebellar embolism | Papillary muscle infarction |
Cerebellar infarction* | Post procedural myocardial infarction |
Cerebral artery embolism | Post procedural stroke |
Cerebral artery thrombosis | Silent myocardial infarction* |
Cerebral infarction* | Stroke in evolution |
Cerebral thrombosis | Sudden cardiac death* |
Cerebrovascular accident* | Thalamic infarction* |
Coronary artery thrombosis | Thrombotic cerebral infarction |
Coronary bypass thrombosis | Thrombotic stroke |
Embolic cerebral infarction | Wallenberg syndrome |
Embolic stroke | Â |